Personalized Peripheral Nerve Stimulation for Inflammatory Bowel Disease

Publication ID: 24-11857778_0006_PTD
Published: October 28, 2025
Category:Direct Improvements & Enhancements

Legal Citation

pr1or.art Inc., “Personalized Peripheral Nerve Stimulation for Inflammatory Bowel Disease,” Published Technical Disclosure No. 24-11857778_0006_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857778_0006_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,778.

Summary of the Inventive Concept

A novel system and method for treating inflammatory bowel disease through personalized peripheral nerve stimulation, leveraging individual autonomic tone and inflammatory response profiles, real-time monitoring, and customized electrical stimulation signals.

Background and Problem Solved

The original patent disclosed systems and methods for treating inflammatory bowel disease through peripheral nerve stimulation. However, it had limitations in terms of individualized treatment and real-time adjustments. The new inventive concept addresses these limitations by incorporating patient-specific profiles, real-time monitoring, and customized electrical stimulation signals to provide more effective and efficient treatment.

Detailed Description of the Inventive Concept

The novel system comprises a stimulation device configured to deliver a customized electrical nerve stimulation signal to a specific peripheral nerve of a patient. The signal is based on the patient's individual autonomic tone and inflammatory response profile, which is monitored in real-time. The system can adjust the electrical stimulation parameters in response to changes in the patient's autonomic tone and inflammatory response profile. Additionally, the system can incorporate data from a patient's gut microbiome to further optimize the treatment. The method involves monitoring the patient's autonomic tone and inflammatory response profile, and adjusting the electrical stimulation parameters accordingly. The system can also access a database of patient profiles and corresponding optimal electrical stimulation parameters to provide personalized treatment.

Novelty and Inventive Step

The new claims introduce the concept of personalized peripheral nerve stimulation, which is novel and non-obvious compared to the original patent. The use of individual autonomic tone and inflammatory response profiles, real-time monitoring, and customized electrical stimulation signals provides a significant improvement over existing treatments.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include the use of different types of sensors to monitor the patient's autonomic tone and inflammatory response profile, such as heart rate variability sensors or cytokine level sensors. The system could also be adapted for use in treating other inflammatory diseases, such as rheumatoid arthritis or lupus.

Potential Commercial Applications and Market

The novel system and method have significant commercial potential in the treatment of inflammatory bowel disease, with an estimated market size of over $10 billion. The personalized approach could also be applied to other inflammatory diseases, expanding the market potential further.

Field of Art

Biomedical engineering, specifically neuromodulation and peripheral nerve stimulation for treating inflammatory diseases, requiring advanced knowledge of electrical stimulation parameters, neurophysiology, and medical device design

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer or medical device researcher with expertise in neurostimulation techniques, electrical signal design, and understanding of autonomic nervous system interactions with inflammatory responses

Obviousness Rationale

A person having ordinary skill in the art would recognize that personalizing nerve stimulation parameters based on individual patient physiological markers is a natural extension of existing peripheral nerve stimulation techniques. The source patent establishes foundational nerve stimulation methodology, while the PTD introduces predictable refinements in signal customization and real-time monitoring. These variations represent incremental improvements using standard engineering design approaches and known principles of personalized medical interventions.

Obvious Combinations & Variations

Source Patent Element
Electrical nerve stimulation with adjustable parameters for specific nerve fiber types
PTD Variation
Real-time adjustment of stimulation parameters based on patient's autonomic tone and inflammatory response profile
Obviousness Reasoning
A PHOSITA would recognize that dynamically adapting stimulation parameters is a predictable optimization technique, leveraging known principles of closed-loop medical device design
Source Patent Element
Transcutaneous peripheral nerve stimulation for inflammatory conditions
PTD Variation
Incorporating gut microbiome data to further customize electrical stimulation signals
Obviousness Reasoning
Integrating additional physiological data for treatment personalization represents a standard engineering approach to improving medical interventions with known techniques
Source Patent Element
Electrical stimulation targeting specific nerve fiber types
PTD Variation
Using a database of patient profiles to match optimal electrical stimulation parameters
Obviousness Reasoning
Developing patient-specific treatment databases is an obvious extension of existing medical informatics and personalized medicine approaches
Source Patent Element
Electrical nerve stimulation with adjustable pulse width and duration
PTD Variation
Designing pulse sequences to mimic natural vagus nerve firing patterns
Obviousness Reasoning
Biomimetic signal design is a predictable approach for medical device engineers seeking to optimize neurological interventions
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857778 and the disclosed variations, a person having ordinary skill in the art would find the claimed personalized peripheral nerve stimulation techniques obvious and anticipated. The incremental modifications represent predictable engineering solutions that would be readily conceived by a skilled practitioner without requiring inventive insight beyond the existing technological landscape.

Original Patent Information

Patent NumberUS 11,857,778
TitleSystems and methods for treating inflammatory bowel disease through peripheral nerve stimulation
Assignee(s)Cala Health, Inc.